Contra-indicated in patients with hypersensitivity to egg or chick embryo protein.
- TRADE NAMES: Stamaril (Sanofi Pasteur); YF-VAX (Sanofi Pasteur)
- INDICATIONS: Immunization against yellow fever
- CLASS: Vaccine
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Azathioprine, Belimumab, Corticosteroids, Fingolimod, Hydroxychloroquine, Immunosuppressants, Interferon-gamma, Leflunomide, Mercaptopurine, Prednisone, Tocilizumab, Ustekinumab
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of yellow fever vaccine in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
